This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Microcrystalline cellulose
DrugBank Accession Number
DB14158
Background

A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.

Type
Small Molecule
Groups
Approved, Experimental, Investigational
Synonyms
  • Cellulose
  • Cellulose crystalline
  • Cellulose powder
  • Cellulose regenerated
  • Cellulose, microcrystalline
  • Cellulose, powder
  • Cellulose, powdered
  • Hydroxycellulose
  • Powdered cellulose
  • Pyrocellulose
  • Rayon
External IDs
  • CP-305

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Cellzyme Secret Therapy 3845Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL)CreamTopicalPHARMACAL-INTERNATIONAL. CO., LTD2017-08-16Not applicableUS flag
Cellzyme Secret Therapy 3845Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL)CreamTopicalPHARMACAL-INTERNATIONAL. CO., LTD2017-08-16Not applicableUS flag
METADONA CLORHIDRATO 40 MG TABLETAMicrocrystalline cellulose (204 mg) + Lactose (342 mg) + Magnesium stearate (18 mg) + Methadone hydrochloride (40 mg) + Silicon dioxide (12 mg)TabletOralBLISTECO S.A.S.2018-06-22Not applicableColombia flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
SMD1X3XO9M
CAS number
9004-34-6

References

General References
Not Available
RxNav
2221
Wikipedia
Microcrystalline_cellulose

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic ScienceChemoreceptor Apnea / Hypoxia / Respiration; Sleep Disorder / Sleep Disordered Breathing (SDB)1
4CompletedBasic ScienceType 2 Diabetes Mellitus1
4CompletedHealth Services ResearchSedation / Surgery1
4CompletedOtherCardiovascular Disease (CVD)1
4CompletedPreventionInflammation / Obesity (Disorder) / Resistance, Insulin1
4CompletedTreatmentIrritable Bowel Syndrome (IBS)1
4CompletedTreatmentSchizophrenia1
4CompletedTreatmentSmoking Addiction1
4RecruitingTreatmentCritically Ill Patients / Shock1
4TerminatedBasic SciencePlatelet Aggregation1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CreamTopical
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at June 29, 2018 15:08 / Updated at September 28, 2021 21:54